BRAF inhibitor shows promising results in pediatric patients with low-grade glioma

BRAF inhibitor shows promising results in pediatric patients with low-grade glioma

Dabrafenib (Tafinlar), a BRAF inhibitor approved to treat certain types of adult melanoma, showed ac...
read more